SEC 13F Intelligence

Managers / Q4 2025 · view latest →

325 CAPITAL LLC

CIK 0001873893 · 757 THIRD AVENUE, 20TH FLOOR, NEW YORK, NY, 10017 · 212-376-5325

Reported Value
$285M
Q4 2025
Positions
13
Filings on Record
18
2019–present window
Filed
Feb 17, 2026
original filing

Summary

325 Capital LLC reported $285M in U.S.-listed holdings across 13 positions for Q4 2025.

The portfolio is heavily concentrated: 51A alone accounts for 20.2% of reported value.

Compared with Q3 2025, the fund opened 1 new position and exited 0.

Portfolio Metrics

Turnover
+15.6%
vs prior filed quarter
Top-10 Concentration
+94.6%
share of reported value
Largest Position
+20.2%
American Pub Ed

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’21: $102MQ4 ’21Q1 ’22: $132MQ2 ’22: $108MQ3 ’22: $86MQ3 ’22Q4 ’22: $92MQ1 ’23: $114MQ2 ’23: $152MQ2 ’23Q3 ’23: $121MQ4 ’23: $202MQ1 ’24: $217MQ1 ’24Q2 ’24: $238MQ3 ’24: $236MQ4 ’24: $259MQ4 ’24Q1 ’25: $241MQ2 ’25: $253MQ3 ’25: $329MQ3 ’25Q4 ’25: $285MQ1 ’26: $274Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 97.3%Other: 2.7%
  • Common Stock · 97.3% · $278M
  • Other · 2.7% · $8M

Quarter-over-Quarter Changes full breakdown →

vs Q3 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
DBDDIEBOLD NIXDORF INCNEW+193.4K193.4K+$13M$13M
MGNIMAGNITE INCADDED+1.36M2.01M+$18M$33M
MULTISENSOR AI HOLDINGS INCADDED+17.11M26.49M+$2M$8M
ATROASTRONICS CORPTRIMMED−1.29M70.0K−$58M$4M
ASTHASTRANA HEALTH INCADDED+645.1K1.84M+$12M$46M
BLBDBLUE BIRD CORPTRIMMED−93.4K679.8K−$13M$32M
AIOTPOWERFLEET INCADDED+191.0K3.84M+$1M$20M
MPAAMOTORCAR PTS AMER INCHELD+02.02M−$8M$25M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2025

13 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
151AAMERICAN PUB ED INChistory →COM20.24%$58M1.53M
2ASTHASTRANA HEALTH INChistory →COM NEW15.99%$46M1.84M
3MGNIMAGNITE INChistory →COM11.40%$33M2.01M
4BLBDBLUE BIRD CORPhistory →COM11.20%$32M679.8K
5MPAAMOTORCAR PTS AMER INChistory →COM8.73%$25M2.02M
6AIOTPOWERFLEET INChistory →COM7.15%$20M3.84M
7LDELIFECORE BIOMEDICAL INChistory →COM6.20%$18M2.16M
8SPIRSPIRE GLOBAL INChistory →COM CL A NEW4.93%$14M1.88M
9DBDDIEBOLD NIXDORF INChistory →COM SHS4.60%$13M193.4K
10BTMDBIOTE CORPhistory →CLASS A COM4.14%$12M4.55M
11MULTISENSOR AI HOLDINGS INCCOM2.67%$8M26.49M
12TACTTRANSACT TECHNOLOGIES INChistory →COM1.42%$4M1.01M
13ATROASTRONICS CORPhistory →COM1.33%$4M70.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$274M12May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$285M13Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$329M12Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$253M11Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$241M11May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$259M12Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$236M11Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$238M13Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$217M12May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$202M13Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$121M8Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$152M9Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$114M9May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$92M7Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$86M8Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$108M10Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$132M9May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$102M9Feb 14, 202213F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.